bioRxiv Science⌕ Search

Biology subjects

Tarkhov, A.

Publications and source records attributed to Tarkhov, A..

2 recordsLinked to original sources

eLaRodON: identification of large genomic rearrangements in Oxford Nanopore sequencing data

Long-read sequencing enables more accurate detection of large genomic rearrangements (LGRs) compared to short-read technologies. However, existing tools for LGR calling continue to evolve and require further optimization. In this study, we present eLaRodON, a novel tool for identifying LGRs in Oxford Nanopore sequencing data. Using publicly available datasets--including Mycobacterium tuberculosis genomes with extensive complete genome references and the human cell line NA12878--we demonstrate that eLaRodON outperforms existing tools (NanoSV, Sniffles2, NanoVar, and SVIM), achieving an AUC of 0.61 (vs. 0.13-0.43) for M. tuberculosis and 0.86 (vs. 0.40-0.72) for the human genome. Validation against gold-standard LGR sets (derived from de novo Flye assemblies and Mauve alignments) confirmed the tools high accuracy. Notably, we identified recurrent false-positive LGR patterns across diverse datasets (M. tuberculosis, NA12878, and {lambda} phage controls). Orthogonal validation by targeted NGS and Sanger sequencing yielded a variant verification rate of 67-100% for different LGR types--including those supported by a single read. These results represent a significant advancement in LGR detection accuracy, with implications for genomic research and clinical applications. eLaRodON is an open-source program, and its code can be freely accessed on GitHub: https://github.com/aakechin/eLaRodON/.

genomics↗

PRC2 clock: a universal biomarker of aging and rejuvenation

DNA methylation (DNAm) is one of the most reliable biomarkers for aging across many mammalian tissues. While the age-dependent global loss of DNAm has been well characterized, age-dependent DNAm gain is less specified. Multiple studies have demonstrated that polycomb repressive complex 2 (PRC2) targets are enriched among the CpG sites which gain methylation with age. However, a systematic whole-genome examination of all PRC2 targets in the context of aging methylome as well as whether these associations are pan-tissue or tissue-specific is lacking. Here, by analyzing DNAm data from different assays and from multiple young and old human and mouse tissues, we found that low-methylated regions (LMRs) which are highly bound by PRC2 in embryonic stem cells gain methylation with age in all examined somatic mitotic cells. We also estimated that this epigenetic change represents around 90% of the age-dependent DNAm gain genome-wide. Therefore, we propose the "PRC2 clock," defined as the average DNAm in PRC2 LMRs, as a universal biomarker of cellular aging in somatic cells. In addition, we demonstrate the application of this biomarker in the evaluation of different anti-aging interventions, including dietary restriction and partial epigenetic reprogramming.

genomics↗